The cobas e 601 module is a fully automated analyzer that uses a patented electrochemiluminescence (ECL) technology for immunoassay analysis.
It is designed for both quantitative and qualitative in vitro assay determinations for a broad range of applications (including anemia; bone, cardiac and tumor markers; critical care; fertility/hormones; maternal care; and infectious diseases).
The cobas e 411 analyzer is a fully automated analyzer that uses a patented ElectroChemiLuminescence (ECL) technology for immunoassay analysis.
It is designed for both quantitative and qualitative in vitro assay determinations for a broad range of applications (including anemia; bone, cardiac and tumor markers; critical care; fertility/hormones; maternal care; and infectious diseases).
The highly reliable IMMULITE® 2000 XPi system is easy to use and has one of the largest automated immunoassay menus available. Medium- to high-volume laboratories can incorporate specialty and allergy testing into routine workloads to improve productivity and efficiency.
Chemiluminescence Immunoassay (CLIA) System
CLIA uses two important technologies, one is labeling technology which determines reaction mode; and the other is
separation technology which determines the sensitivity, accuracy and precision of the reagents.
Sample Loading
Up to 144 primary tubes, Continuous loading, STAT available, Barcode reader recognition or analyzer auto numbered, LIS connection, auto read sample info, Refrigerated sample area with independent power supply
Reagent Loading
25 reagents on board, Continuous loading, RFID reading all info of reagents, Refrigerated reagent area.
Reagent Features
Integrated kit, ready-to-use, no pretreatment required, Integrated kit including calibrators, Using superparamagnetic micrbeads, RFID tag storing all info of reagent, RFID tag with built-in master curve, 2-point calibration to adjust master curve, Calibration stability: Max 4 weeks.
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction
This Section Is Under Construction